TULSA and the External Sphincter: A Retrospective Analysis

TULSA and the External Sphincter: A Retrospective Analysis

At RSNA 2023 in Chicago, Dr. Busch presented on the retrospective analysis of MRI-guided transurethral ultrasound ablation (TULSA) in prostate cancer lesions at the extreme apex. The clinical findings show TULSA is a promising prostate cancer treatment with minimal...
The Heart of Busch Center

The Heart of Busch Center

While Busch Center is rooted in over 40 years of experience with a passion for preserving quality of life for those diagnosed with prostate cancer or BPH, it’s also rooted in the hearts of our founders, Dr. Joe and Kathy Busch.  What started as a “typical” event...
TULSA: Bringing Hope After Radiation Therapy

TULSA: Bringing Hope After Radiation Therapy

In the medical field, it’s unfortunately still common practice to recommend a prostatectomy directly following a prostate cancer diagnosis despite the growing knowledge of safer alternatives. Prostatectomy surgery involves removing the prostate which can lead to a...